Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncor and Becton Dickinson enter licence agreement:

This article was originally published in Clinica

Executive Summary

Oncor and BD Microbiology Systems, a division of Becton Dickinson, have signed a licence agreement for Oncor's Sunrise Detection System which uses closed-tube amplification technology. Under the agreement Oncor, which is based in Gaithersburg, Maryland, will receive licence fees, royalties, milestone payments and sponsored research funding. BD Microbiology Systems will use the Sunrise technology in future diagnostic tests alongside its Strand Displacement Amplification technology.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT080872

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel